<![CDATA[FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care]]>
The Food and Drug Administration (FDA) has granted accelerated approval to the first-in-class cereblon E3 ligase modulator (CELMoD) iberdomide (Zenbexus) in combination with daratumumab, hyaluronidase-fihj, and dexamethasone (IberDd) for adults with …